New weekly shot shows promise for kids with dwarfism
Disease control
Completed
This trial tested whether a weekly injection could safely increase growth rate in children aged 2-11 with achondroplasia, a genetic condition that causes short stature. For one year, some children received the active injection while others received a placebo, followed by another …
Phase: PHASE2, PHASE3 • Sponsor: Ascendis Pharma Growth Disorders A/S • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC